Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics · 2008
Dental and periodontal history of oncologic patients on parenteral bisphosphonates with or without osteonecrosis of the jaws: a pilot study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Carmagnola Daniela, Celestino Silvio, Abati Silvio
Аннотация
OBJECTIVES: We tested the hypothesis that patients on bisphosphonates with ONJ might have a poorer dental and periodontal history than non-ONJ patients. Our aim was to retrospectively compare medical and oral history of patients on bisphosphonates with and without ONJ.
STUDY DESIGN: A total of 39 oncologic patients on bisphosphonates were interviewed, examined, and had a panoramic radiograph taken. DMFT values and residual bone levels were calculated and compared for ONJ and non-ONJ patients.
RESULTS: Twenty of 39 patients had ONJ. No statistical differences in caries or residual bone level as well as dental extractions were detected, although twice as many patients with ONJ underwent dental extractions. ONJ patients had received statistically more administrations of bisphosphonates compared to non-ONJ patients.
CONCLUSION: A long history of bisphosphonate administration might represent a risk for ONJ onset.
STUDY DESIGN: A total of 39 oncologic patients on bisphosphonates were interviewed, examined, and had a panoramic radiograph taken. DMFT values and residual bone levels were calculated and compared for ONJ and non-ONJ patients.
RESULTS: Twenty of 39 patients had ONJ. No statistical differences in caries or residual bone level as well as dental extractions were detected, although twice as many patients with ONJ underwent dental extractions. ONJ patients had received statistically more administrations of bisphosphonates compared to non-ONJ patients.
CONCLUSION: A long history of bisphosphonate administration might represent a risk for ONJ onset.
Предметные рубрики MeSH
AgedAged, 80 and overAlveolar Bone LossAntineoplastic AgentsBone Density Conservation AgentsDMF IndexDiphosphonatesFemaleHumansImidazolesJaw DiseasesMaleMiddle AgedNeoplasmsOsteonecrosisPeriodontal IndexPilot ProjectsRetrospective StudiesRisk FactorsStomatitis, DentureTooth ExtractionZoledronic Acid